Insulet Corp (PODD) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Insulet Corp (Insulet) is a medical device company that develops, manufactures and distributes insulin management systems for diabetic patients. Its OmniPod insulin management system is a continuous insulin delivery system for insulin dependent diabetic s. Omnipod system consists of a disposable self-adhesive tubeless insulin infusion device, OmniPod, and a handheld wireless device, Personal Diabetes Manager. The company also works in partnership with biotechnology and pharmaceutical companies that utilize the customized form of its Omnipod system to deliver drugs at specified intervals of time at predetermined doses. The company markets and sells its products directly and through distribution partners in North America, Asia and Europe. Insulet is headquartered in Billerica, Massachusetts, the US.

Insulet Corp (PODD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Insulet Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Insulet Corp, Medical Devices Deals, 2012 to YTD 2018 9
Insulet Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Insulet Corp, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Insulet Acquires Distribution Rights from GlaxoSmithKline 11
Debt Offering 12
Insulet Raises Private Placement of Senior Notes for USD345 Million 12
Insulet Prices Public Offering of 2% Notes Due 2019 for USD175 Million 13
Asset Transactions 15
Sinoxa Pharma Acquires Patent Rights To Omnipod Patch-Pump Technology From Insulet 15
Insulet Corp - Key Competitors 16
Insulet Corp - Key Employees 17
Insulet Corp - Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
May 03, 2018: Insulet Reports First Quarter 2018 Financial Results 19
Nov 02, 2017: Insulet Reports Third Quarter 2017 Financial Results 21
Aug 03, 2017: Insulet Reports Second Quarter 2017 Financial Results 22
May 08, 2017: Insulet Reports First Quarter 2017 Financial Results 23
Feb 27, 2017: Insulet Reports Fourth Quarter and Full Year 2016 Financial Results 24
Corporate Communications 26
Aug 10, 2017: Insulet Appoints Michael R. Minogue and James C. Mullen to Board of Directors 26
May 30, 2017: Insulet Appoints Bret Christensen as Chief Commercial Officer 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List Of Tables

List of Tables
Insulet Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Insulet Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Insulet Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Insulet Corp, Medical Devices Deals, 2012 to YTD 2018 9
Insulet Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Insulet Acquires Distribution Rights from GlaxoSmithKline 11
Insulet Raises Private Placement of Senior Notes for USD345 Million 12
Insulet Prices Public Offering of 2% Notes Due 2019 for USD175 Million 13
Sinoxa Pharma Acquires Patent Rights To Omnipod Patch-Pump Technology From Insulet 15
Insulet Corp, Key Competitors 16
Insulet Corp, Key Employees 17
Insulet Corp, Other Locations 18
Insulet Corp, Subsidiaries 18

List Of Figures

List of Figures
Insulet Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Insulet Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Insulet Corp, Medical Devices Deals, 2012 to YTD 2018 9

Insulet: Performance, Capabilities, Goals and Strategies in the Global Medical Devices Market

This report is part of the Competitive Analysis Series prepared by LeadingMarketResearch.com to help current suppliers and potential market entrants realistically assess their financial, technological and marketing capabilities in relation

USD 950 View Report

Insulet Corp (PODD) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Insulet Corp (Insulet) is a medical device company that develops, manufactures and distributes insulin management systems for diabetic patients. Its OmniPod insulin management system is a continuous insulin delivery system

USD 250 View Report

Insulet Corporation Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Insulet Corporation Company Profile is a detailed strategic and analytical report on Insulet Corporation. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200 View Report

Insulet Corp (PODD) - Product Pipeline Analysis, 2018 Update

Insulet Corp (Insulet) is a medical device company that develops, manufactures and distributes insulin management systems for diabetic patients. Its OmniPod insulin management system is a continuous insulin delivery system

USD 750 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available